- The Indian equity markets were up on May 15th with the Nifty rising 23 points to close at 6,169.90 and the Sensex rising 34 points to close at 20,247.33. European markets were mixed with the FTSE up nearly 9 points and the DAX down around 10 points. - Foreign institutional investors purchased Indian stocks worth Rs. 1,646 crores on May 15th while domestic institutional investors sold stocks worth Rs. 747 crores. - Key pharmaceutical stocks like Lupin and Glenmark rose to new highs, with Lupin gaining over 3% to hit a record high of Rs. 810.80 per share.

1. -=6
HEADLINES
 Indian Market
 Indian equity markets were up 0.38%
 Nifty up by 23.15 pts and settle at
6169.90
 Sensex up by 34.37 pts at 20247.33
 Bank Nifty up by 161.60 pts at 13239.50
 Global Market
 European markets were up with FTSE
up by 8.99 closed at 6702 ,CAC down by
10.34 closed at 3971 and DAX down 9.82
closed at 8352
Dow future was up by 1 closed at
15236.00
WWW.EPICRESEARCH.CO 09752199966
DAILY EQUITY
NEWSLETTER
17TH
MAY 2013
 HEADLINES
• AirAsia's Chandilya will have to be cost
leader in India
• RBI to kickstart sale of inflation-indexed
bonds on June 4
• Adani Ports Q4 net profit triples to Rs
710.31 cr
• CARE's Q4 revenue at Rs 63 crore, net
at Rs 36 crore

2.  FII’s and DII’s
CATEGORY DATE BUY SELL NET
FII 15-May-13 4362.4 2715.45 1646.95
DII 15-May-13 1244.05 1991.16 -747.11
 NIFTY DAILY PIVOTS
PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4
NIFTY 6338 6279 6220 6194 6161 6135 6102 6043 5984
WWW.EPICRESEARCH.CO 09752199966
MARKET ANALYSIS:
 Key benchmark indices nudged higher as index heavyweight Reliance Industries (RIL) gained. The
barometer index, the S&P BSE Sensex, was provisionally up 34.31 points or 0.7%, off close to 80
points from the day's high and up about 85 points from the day's low. The market breadth, indicating
the overall health of the market, was negative.
 Index heavyweight and cigarette major ITC dropped ahead of its Q4 results tomorrow, 17 May 2013.
Auto stocks fell. Bajaj Auto declined on reporting weak Q4 results. Pharma stocks rose on renewed
buying, with Lupin hitting record high and Glenmark Pharmaceuticals hitting 52-week high. Reliance
Capital turned volatile after reporting weak Q4 results.
 Indian stocks gained for the third straight day today, 16 May 2013.Foreign institutional investors (FIIs)
bought shares worth a net Rs 1646.95 crore on Wednesday, 15 May 2013, as per provisional data from
the stock exchanges.
 As per provisional figures, the S&P BSE Sensex was up 34.31 points or 0.7% to 20,247.27. The index
rose 113.52 points at the day's high of 20,326.48 in morning trade, its highest level since 6 January
2011. The index fell 50.84 points at the day's low of 20,162.12 in opening trade. Pharma stocks rose on
renewed buying. Cipla, Dr Reddy's Laboratories, and Ranbaxy Laboratories rose by 2.3% to 3.04%.
Sun Pharmaceutical Industries fell 0.39%.Lupin rose 3.08% to Rs 806.60. The stock hit record high of
Rs 810.80 in intraday trade today, 16 May 2013.
STOCKS TO WATCH
 BAJAJ AUTO
 CAIRN INDIA
 TCS
 INFOSYS
SCRIPS IN BAN PERIOD

3. WWW.EPICRESEARCH.CO 09752199966
.
EXPERT OPINION
NIFTY
 Nifty looks Bearish
 Strategy: Sell on rise
 Support: 6100
 Resistance: 6200
BANK NIFTY
 Bank Nifty looks Bearish
 Strategy: Sell on rise
 Support: 13000
 Resistance: 13150
460
 .0
 GAINERS AND LOOSERS
PREVIOUS PERFORMANCE
TYPE SCRIP B/S RESULT
CASH
RELIANCE
COMMUNICATION
B TGT HIT
CASH VOLTAS B TGT HIT
FUTURE APOLLO TYRE B TGT HIT
FUTURE ADANI POWER S
NOT
EXECUTED
DAILY NIFTY GAINERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHANG
E
JP
Associate
80.05 32873.81 75.80 4.25 5.61
IDFC 163.35 9529.19 158.05 5.30 3.35
Lupin 806.90 1775.87 782.00 24.90 3.18
Cipla 422.10 2601.21 411.10 11.00 2.68
Reliance
Indus
840.65 3473.90 819.00 21.65 2.64
DAILY NIFTY LOOSERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHAN
GE
NMDC 124.55 2382.96 128.35 -3.80 -2.96
Tata
Motors
303.65 5186.19 308.85 -5.20 -1.68
ITC 337.00 7384.78 342.45 -5.45 -1.59
Jindal
Steel &
Power
308.35 2629.50 312.70 -4.35 -1.39
TCS 1454.05 1207.83 1471.55 -17.50 -1.19

4. 6
.
MARKET CALLS
CASH
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET STOP LOSS
ALLAHBAD BANK BUY 127.00 128.00 129.00 126.00
SESA GOA BUY 168.50 169.50 170.50 167.50
FUTURE
SCRIPS ACTION LEVEL 1
ST
TARGET 2
ND
TARGET STOP LOSS
APOLLO TYRE BUY 92.60 93.10 93.60 92.10
CROMPTON
GREAVES
BUY 97.40 97.90 98.40 96.90
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on
sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually
tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and
encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on
the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks
recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of
the information is the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any
financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to
buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls
or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious
Legal Actions can be taken.